Filing Flows

Filing Flows › Guardian Pharmacy Services (GRDN) › Q3 2025

Guardian Pharmacy Services (GRDN) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 10, 2025

Guardian Pharmacy Services (GRDN) reported revenue of $377M for the third quarter 2025 (Q3 2025), +20% from a year earlier and +10% from the quarter before. Operating margin was 4.3%, net earnings $9.8M (2.6% of revenue).

Revenue$377M
Year over year+20%
Quarter over quarter+10%
Operating margin4.3%
Net earnings$9.8M

Guardian Pharmacy Services, Q3 2025: revenue $377M (+20% year over year), operating margin 4.3%, net earnings $9.8M, operating cash flow $28.2M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$377M+10%+20%
Gross profit$74.7M+10%+23%
Operating profit$16.4M+30%—
Net earnings$9.8M+9%—
Operating cash flow$28.2M+41%—
Free cash flow$24.2M——

What changed

Revenue was $377.4M in Q3 2025, up 20% year over year and up 10% from the previous quarter.

Gross margin was 19.8%, up 0.4 points from a year earlier. Operating profit was $16.4M, a 4.3% margin (up 37.6 points year over year). Operating expenses fell 65% while revenue rose 20%. Net earnings were $9.8M. The effective tax rate was 42.3%.

Operating cash flow was $28.2M, 294% of net income including minority interests. Non-cash charges added back $5.8M of depreciation and amortization and $4.4M of share-based compensation. Working capital and other items added $8.4M. Capital expenditures of $4.0M left free cash flow of $24.2M.

Questions

What was Guardian Pharmacy Services' revenue in the third quarter 2025?

Guardian Pharmacy Services (GRDN) reported revenue of $377M for the third quarter 2025 (Q3 2025), +20% from a year earlier and +10% from the quarter before.

Was Guardian Pharmacy Services profitable in the third quarter 2025?

Operating profit was $16.4M (4.3% of revenue) and net earnings $9.8M.

Open the interactive Sankey →

Source: Guardian Pharmacy Services 10-Q on SEC EDGAR.